Quarter
Charts
🇺🇸US Markets

Warby Parker Inc.

WRBY

CIK 0001504776 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$212M
↑+11.2% +$21Mvs FY2024 (Q4)
Gross Profit
$111M
↑+7.7% +$8Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
54/100
  • Profitability
    0ROIC -0.8% (10% = solid, 20%+ = moat)
  • Liquidity
    92Current Ratio 2.35 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    79Asset Turnover 1.22x (1.0+ = capital-efficient)
  • Growth
    54Revenue YoY +11.2% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 1.6% · trend +3.8pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project WRBY's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$6.01
Total enterprise IV
$752M
Diluted shares
0.13B
Terminal PV
$545M (72% of total)
Year-5 FCF
$64M
YearProjected FCFDiscounted PV
+1$47M$43M
+2$51M$42M
+3$55M$41M
+4$60M$41M
+5$64M$40M
Terminal$878M$545M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$67M
investment in PP&E
Stock buybacks (TTM)
—
share count reduction
Stock-based comp (TTM)
$35M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$721M
everything owned
Total liabilities
$353M
everything owed
Stockholders' equity
$368M
shareholder claim

Recent performance · 24 quarters

Revenue↑+11.2% +$21M
$212M
Net Income↑+244.3% +$10M
$6M
Free Cash Flow↑+271.2% +$6M
$8M
Operating Margin↑+5.0pts
1.6%

Drill down